Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-01 15:40:30 - browse：8566

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

In other words, a lot like the content below. I’m really excited to get started and I hope you’ll find the newsletter worthy of your inbox real estate.

This week: A deep dive into the bull and bear sides of the Applied Therapeutics debate, and another well-deserved swipe at Cassava Sciences and its entirely ridiculous Alzheimer’s drug candidate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Goldman Sachs launches $650M fund for life science investments

entertainment

WSS

3 trends to watch in health tech's hiring outlook for 2024

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Morgan Health, with ambitious aims, wants you to know it’s still here

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Canadians with cystic fibrosis outlive Americans by a decade

leisure time

Wikipedia

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Apple is now the first public company to be valued at $3 trillion

The FDA must approve intranasal treatments for anaphylaxis

Supreme Court strikes down use of affirmative action

New weight loss drugs work. But how can they best be used?

United colonoscopy coverage change 'may cost lives,' doctors say

Federal weight loss drug coverage is 30 years out of date

leisure time

Goldman Sachs launches $650M fund for life science investments

Feng Zhang, Grail founder join forces on new gene editing startup

AdventHealth escalates lawsuit against insurance vendor Multiplan

Chronically ill young patients struggle to find fertility info

UCB departs biotech trade group BIO

Dexcom's push to bring CGM to type 2 diabetes patients

focus

entertainment

leisure time

entertainment